Literature DB >> 23432346

Erlotinib-induced hair repigmentation.

Yu-Pin Cheng1, Hsiang-Jung Chen, Hsien-Ching Chiu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23432346     DOI: 10.1111/j.1365-4632.2011.05422.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  6 in total

1.  Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer.

Authors:  Noelia Rivera; Aram Boada; M Isabel Bielsa; M Teresa Fernández-Figueras; Enric Carcereny; M Teresa Moran; Carlos Ferrándiz
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

Review 2.  Medication-Induced Repigmentation of Gray Hair: A Systematic Review.

Authors:  Katerina Yale; Margit Juhasz; Natasha Atanaskova Mesinkovska
Journal:  Skin Appendage Disord       Date:  2019-12-17

Review 3.  Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Authors:  Julia Dai; Viswanath R Belum; Shenhong Wu; Vincent Sibaud; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09-14       Impact factor: 11.527

Review 4.  Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.

Authors:  K Chanprapaph; V Vachiramon; P Rattanakaemakorn
Journal:  Dermatol Res Pract       Date:  2014-03-02

5.  Hair repigmentation associated with the use of brentuximab.

Authors:  Lauren R Penzi; Athena Manatis-Lornell; Arturo Saavedra; David Fisher; Maryanne M Senna
Journal:  JAAD Case Rep       Date:  2017-11-08

Review 6.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.